EmeTerm develops precise, wearable and smart medical products to prevent debilitating conditions like nausea. Current medical solutions often involve drug intake, which can cause further discomfort through various side-effects.
EmeTerm develops technologies that use non-invasive neuronal electrical stimulation, including transcutaneous electrical acupoint stimulation (TEAS) and transcranial direct current stimulation (tDCS), which involve electrical currents conducted from the skin.
EmeTerm consists of leaders in the field of medical research and product development who are devoted to provide effective and convenient therapy options to users around the world.
